• Conference Proceeding

Validating A Cost-Effectiveness Analysis Comparing Olanzapine with Ziprasidone in the Treatment of Schizophrenia

Citation

Graham, C., Mauskopf, J., Lawson, A. H., Ascher-Svanum, H., Bruhn, D., & Watson, P. R. (2010). Validating A Cost-Effectiveness Analysis Comparing Olanzapine with Ziprasidone in the Treatment of Schizophrenia. In [13], pp. A113–A113. .

Abstract